News & Updates

Show Multimedia Only
Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
01 Apr 2025 byAudrey Abella

In the absence of infant hepatitis B immune globulin (HBIg), maternal tenofovir disoproxil fumarate (TDF) prophylaxis combined with infant hepatitis B virus (HBV) immunization provide sufficient protection against HBV infection in infants, findings from the iTAP-2 study suggest. However, the risk of infection was not demonstrably below 2 percent.

Maternal TDF, infant HBV vax, HBIg-free strategy prevent infant hep B
01 Apr 2025
Family history of CRC ups risk of adenoma, neoplasia
Family history of CRC ups risk of adenoma, neoplasia
17 Mar 2025 byStephen Padilla

Individuals with a family history of colorectal cancer (CRC) are at greater risk of developing adenoma, nonadvanced adenoma (NAA), advanced adenoma (AA), and advanced neoplasia (AN), reveals a study.

Family history of CRC ups risk of adenoma, neoplasia
17 Mar 2025